Stanisław Jesionek

Stanisław Jesionek

Auto-generated profile, based on publicly available information

Stanisław Jesionek

Pabianice Medical Center Sp. o.o., ul. Jana Pawła II 68, 95-200 Pabianice, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AWAleksandra Witek
Aleksandra Witek
JPJakub Parys
Jakub Parys
AMAgnieszka Mikosińska
Agnieszka Mikosińska
MKMartyna Kaźmierczak
Martyna Kaźmierczak
MMMaciej Mossakowski
Maciej Mossakowski
RBRafał Bieś
Rafał Bieś
Introduction and purpose:This review is intended for healthcare professionals, including dermatologists, primary care physicians, and researchers, who seek a comprehensive understanding of vitiligo. It is also relevant for patients and their families to better understand the condition. The review is indicated for those dealing with cases of vitiligo that are difficult to diagnose or manage, those with widespread or refractory vitiligo, and individuals interested in the latest advancements in treatment. The purpose of this review is to provide a detailed analysis of vitiligo’s etiopathogenesis, the current diagnostic methods, and the most effective treatment options. By exploring the genetic, autoimmune, and environmental factors involved in vitiligo, the review aims to enhance the understanding of the disease's origin and progression. Additionally, it seeks to offer evidence-based insights into the most up-to-date diagnostic tools and therapeutic approaches, ultimately improving patient care and guiding future research directions. State of knowledge: Vitiligo is an autoimmune disorder characterized by the loss of melanocytes, leading to depigmented skin patches. Its exact cause remains unclear, but genetic and environmental factors, such as stress and skin trauma, are thought to contribute. Diagnosis is primarily clinical, with dermoscopy and biopsy used in uncertain cases. While treatments like topical corticosteroids, phototherapy, and JAK inhibitors are effective for some, no cure exists, and responses vary widely. Surgical options like melanocyte transplantation can help with localized cases. Ongoing research aims to better understand the disease mechanisms and improve treatment outcomes.

7 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MKMartyna Kaźmierczak
Martyna Kaźmierczak
JPJakub Parys
Jakub Parys
AMAgnieszka Mikosińska
Agnieszka Mikosińska
PKPatrycja Kałuziak
Patrycja Kałuziak
MJMarta Jajczak
Marta Jajczak
SJStanisław Jesionek
Stanisław Jesionek
Background: Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine and metabolic disorder that affects women of reproductive age, characterized by hormonal imbalances, insulin resistance, and a range of clinical manifestations, including infertility and metabolic disturbances. Effective management of PCOS remains a challenge due to its multifaceted nature, necessitating a comprehensive understanding of therapeutic options. Aim of the Study: This paper aims to explore the role of various treatment modalities for PCOS, with a particular emphasis on the use of metformin, an antidiabetic medication increasingly recognized for its benefits in managing insulin resistance and other associated conditions in PCOS patients. Conclusion: The findings highlight metformin's three primary mechanisms of action: enhancing insulin sensitivity, inhibiting hepatic gluconeogenesis, and influencing lipid metabolism. Metformin is effective in improving metabolic parameters and restoring ovulatory function in women with PCOS. While it is a cornerstone of therapy, the management of PCOS requires a tailored approach that considers individual clinical symptoms and phenotypes. Additional therapeutic strategies, including non-pharmacological measures and other pharmacological agents, play a vital role in a comprehensive treatment plan for PCOS.

12 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PKPatrycja Kałuziak
Patrycja Kałuziak
JPJakub Parys
Jakub Parys
AMAgnieszka Mikosińska
Agnieszka Mikosińska
MKMartyna Kaźmierczak
Martyna Kaźmierczak
MJMarta Jajczak
Marta Jajczak
SJStanisław Jesionek
Stanisław Jesionek
Background: Urinary tract infections (UTIs) are common in pregnant women due to significant changes during gestation. UTIs can affect any part of the urinary system and are typically caused by bacteria, though fungi and viruses can also be responsible. Asymptomatic bacteriuria (ASB is frequent in pregnancy and must be treated to prevent serious maternal and fetal complications. Routine screening for ASB is standard in prenatal care, and treatment with safe, effective antibiotics is essential. Preventive strategies also help reduce UTI during pregnancy. Aim of the study: The study aimed to explore the changes that occur during gestation, which predispose pregnant women to UTIs, assess the diagnostic methods and select the most effective treatment to prevent complications. State of knowledge: Urinary tract infections (UTIs) are common perinatal complications, with higher prevalence in pregnancy due to changes that occur during gestation. UTIs can perform as asymptomatic bacteriuria (ASB), cystitis and pyelonephritis, which can result in severe complications. Clinical guidelines recommend screening for ASB in early pregnancy and prescribing a short course of antibiotics if detected. Escherichia coli is the most common cause of UTIs. As most antibiotics cross the placenta, treatment must be safe for the fetus and effective against the pathogens. Guidelines recommend short courses of antibiotics. Conclusions: UTIs in pregnancy are common and lead to serious complications if untreated. Pregnant women are more susceptible to UTIs due changes that occur during gestation. Healthcare professionals play a critical role in managing UTIs during pregnancy. Early detection through routine screening and prompt treatment is crucial for optimal outcomes. Healthcare professionals, including obstetricians, should educate patients on preventive measures and recognizing early UTI symptoms. Abbreviations: UTIs- urinary tract infections; ASB- asymptomatic bacteriuria

3 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MJMarta Jajczak
Marta Jajczak
JPJakub Parys
Jakub Parys
AMAgnieszka Mikosińska
Agnieszka Mikosińska
MKMartyna Kaźmierczak
Martyna Kaźmierczak
AWAleksandra Witek
Aleksandra Witek
SJStanisław Jesionek
Stanisław Jesionek
Introduction: Snus is a tobacco-containing product particularly popular in Scandinavian countries. It comes in the form of a pouch filled with tobacco, which is typically placed under the upper lip, allowing nicotine to be absorbed through the mucous membrane. Due to the absence of combustion during snus use—and consequently the lack of substances produced by this process—many manufacturers claim that snus is a healthier alternative to cigarettes. The aim of this article is to review scientific studies examining the effects of snus on the human body and to objectively summarize its impact on human health. Materials and Methods: This study was conducted by collecting scientific articles from the PubMed database and other online scientific databases. The articles were identified using keywords such as "snus," "smokeless tobacco," and "snus health impact." Results: Snus cannot be considered a healthier alternative to tobacco use. While it does not cause many of the diseases associated with smoking and the toxic compounds produced during combustion, it is still addictive and contributes to other health issues caused by the substances it contains and the way it is consumed. This product requires more detailed scientific research.

8 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AMAgnieszka Mikosińska
Agnieszka Mikosińska
MLMateusz Litwin
Mateusz Litwin
JPJakub Parys
Jakub Parys
PKPatrycja Kałuziak
Patrycja Kałuziak
AWAleksandra Witek
Aleksandra Witek
MMMaciej Mossakowski
Maciej Mossakowski
Introduction: Bisphosphonates are pharmacological agents that inhibit bone resorption by targeting osteoclasts, thereby increasing bone density and reducing fracture risk. Although they were first synthesized in the 19th century, their clinical significance has only been recognized in the last 50 years. This study reviews the current understanding of bisphosphonates, their therapeutic advantages in various disorders, and their mechanism of action, potential interactions, and adverse effects. Aim of the study: The aim of this study is to provide an overview of the current understanding of bisphosphonates and familiarize readers with their mechanisms of action, interactions and adverse effects. It also aims to briefly introduce diseases that may be treated with bisphosphonates and how this class of medications can improve the course of each disorder. This study focuses on their therapeutic potential and associated risks, highlighting the need for further research in this area. Material and methods: Literature available in the PubMed database was reviewed using the following keywords: “bisphosphonates”; “bisphosphonates mechanism of action”; “bisphosphonates side effects”; “bisphosphonates interactions”; “bone tissue”; “skeletal system disorders”; “skeletal system”; “menopause”;” osteogenesis imperfecta”; “bone metastasis” Conclusions: The introduction of bisphosphonates represents a significant advancement in the management of conditions associated with increased bone turnover, offering clinically substantiated benefits that outweigh the associated risks. This review provides healthcare professionals with evidence-based, scientifically validated information on bisphosphonates, while also identifying critical areas for further investigation to optimize their safety and efficacy, ultimately improving patient outcomes and quality of life.

17 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
MLMateusz Litwin
Mateusz Litwin
AMAgnieszka Mikosińska
Agnieszka Mikosińska
JPJakub Parys
Jakub Parys
PKPatrycja Kałuziak
Patrycja Kałuziak
AWAleksandra Witek
Aleksandra Witek
MMMaciej Mossakowski
Maciej Mossakowski
Introduction: Hepatitis B remains a significant clinical issue. Despite the availability of effective vaccines, the world is still not free from this problem. Chronic hepatitis B virus (HBV) infection affects approximately 296 million people worldwide and is the leading cause of cirrhosis and liver cancer globally. HBV-related cirrhosis resulted in an estimated 331,000 deaths in 2019, and it is estimated that the number of deaths from HBV-related liver cancer in 2019 was 192,000, an increase from 156,000 in 2010. The rate of vaccination is particularly unsatisfactory in low-income countries, but even in high-income countries, the issue of hepatitis B has not been completely eradicated. Aim of the study: The aim of this paper is primarily to systematize knowledge regarding the natural course of HBV infection and therapeutic options for chronic hepatitis B, both in adults and children. It also aims to highlight the principles of monitoring pharmacotherapy. The paper also describes therapeutic possibilities in special cases, such as pregnancy, liver transplantation, and the initiation of immunosuppressive therapy. Attention is also given to the potential adverse effects of pharmacotherapy. Conclusions: As hepatitis B infection continues to pose a significant global health challenge and remains the leading cause of liver cirrhosis and hepatocellular carcinoma, it is essential to review the available treatment options for this condition. Even in Europe, where vaccination coverage has reached high levels, cases of hepatitis B are still detected, often incidentally. This review aims to provide an in-depth analysis of therapeutic approaches for chronic hepatitis B, considering factors such as patient age, clinical status, and liver fibrosis stage. Additionally, it emphasizes the importance of monitoring treatment efficacy and safety, while also addressing the potential adverse effects associated with antiviral therapy.